EURO RX Arzneimittel GmbH, based in Wedemark, operates wholesale trade in prescription medicines and carries out purchases and sales both nationally and internationally, with a focus on Germany and European markets. In the 2021 financial year revenue volume increased by 6.7% versus the prior year; gross profit amounted to €3,465,877.94 and net income to €280,227.18. The company employed on average 35 employees (prior year: 28). EURO RX is classified as a medium-sized corporation under §267 HGB, is registered at the Hannover local court under HRB 58532, and has share capital of €25,000.00.
Die Herstellung, der Handel, die Forschung und die Beratung im Arzneimittel- und Medizinbereich, die Digitalisierung von pharmazeutischen Leistungserbringungen im Gesundheitswesen sowie alle jeweils damit verbundenen Geschäfte.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Hannover Local Court, HRB 58532 (as of 28 October 2026)
| Name | Type | City |
|---|---|---|
| Sascha Knoche | Geschäftsführer(in) | Wedemark |
Source: German Commercial Register (Handelsregister) Hannover Local Court, HRB 58532 (as of 28 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 27.08.2024 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 08.12.2021 | Business Purpose Update | Die Herstellung, der Handel, die Forschung und die Beratung im Arzneimittel- und Medizinbereich, die Digitalisierung von pharmazeutischen Leistungserbringungen im Gesundheitswesen sowie alle jeweils damit verbundenen Geschäfte. |
| 08.12.2021 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 27.08.2024 | Capital Increase | +7.954 € | 32.954 € |
| 06.03.2006 | Share Capital Set | — | 25.000 € |
Source: German Commercial Register (Handelsregister) Hannover Local Court, HRB 58532 (as of 28 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2021 | Rohergebnis€3.5M2 | €281,979 | €12,117,426 | — |
| 2020 | Rohergebnis€4.1M2 | €971,843 | €11,117,522 | — |
| 2019 | Rohergebnis€2.5M2 | €249,840 | €6,758,819 | — |
| 2018 | Rohergebnis€2.2M2 | €101,158 | €6,644,472 | — |
| 2017 | Rohergebnis€2.5M2 | €311,361 | €8,077,558 | — |
| 2016 | small company1 | €67,297 | €5,946,440 | — |
| 2015 | ≤ €12M1 | €205,367 | €7,250,802 | — |
| 2014 | small company1 | €279,161 | €5,714,301 | — |
| 2013 | small company1 | €195,091 | €4,633,583 | — |
| 2012 | small company1 | €265,424 | €2,636,449 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Hannover Local Court, HRB 58532 (as of 28 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €1,455,953 | 84.5% |
| Depreciation | €100,862 | 5.9% |
| Interest & Similar | €166,209 | 9.6% |
